Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.
Status:
Completed
Trial end date:
2020-05-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of TAS5315 in combination with
methotrexate in a 12 week or 36 week in participants with rheumatoid arthritis with
inadequate response to methotrexate.